Cytokinetics Inc Earnings

The next earnings date for Cytokinetics Inc is October 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Cytokinetics Inc Earnings

Report DateEstimated Earnings Per Share
10/30/2025$-1.57

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Cytokinetics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/07/2025---$0100.00%
07/31/2025---$0100.00%
05/06/2025After Market$-1.360.23%
02/25/2025After Market$-1.26-7.33%
11/06/2024After Market$-1.36-8.80%
08/08/2024After Market$-1.31-23.58%
05/08/2024After Market$-1.33-16.67%
02/27/2024After Market$-1.38-42.27%
11/02/2023After Market$-1.35-82.43%
08/03/2023After Market$-1.34-16.52%
05/04/2023After Market$-1.38-15.00%
03/01/2023After Market$-1.45-19.83%
11/03/2022After Market$-1.52-29.91%
08/04/2022After Market$-0.2377.45%
05/04/2022After Market$-1.02-8.51%
02/24/2022After Market$-0.3657.14%
11/03/2021After Market$-0.95-23.38%
08/05/2021After Market$-0.86-30.30%
05/06/2021After Market$-0.66-13.79%
02/25/2021After Market$-0.62-106.67%
11/04/2020After Market$-0.0585.29%
08/06/2020After Market$-0.68-19.30%
05/06/2020After Market$-0.66-32.00%
03/03/2020After Market$-0.52-18.18%
10/31/2019After Market$-0.50-2.04%
08/08/2019After Market$-0.56-12.00%
05/09/2019After Market$-0.54-14.89%
02/21/2019After Market$-0.487.69%
11/01/2018After Market$-0.4021.57%
07/26/2018After Market$-0.510.00%
04/26/2018After Market$-0.56-12.00%
02/15/2018After Market$-0.75-7.14%
10/26/2017After Market$-0.603.23%
08/02/2017After Market$-0.60-5.26%
04/27/2017After Market$-0.62-138.46%
02/16/2017After Market$0.16161.54%
10/27/2016After Market$0.74355.17%
07/28/2016After Market$-0.296.45%
04/28/2016After Market$-0.318.82%
02/16/2016After Market$-0.2425.00%
10/29/2015After Market$-0.2323.33%
07/29/2015After Market$-0.27-17.39%
04/30/2015After Market$-0.23-91.67%
02/12/2015After Market$0.23235.29%
10/30/2014After Market$-0.1633.33%
07/30/2014---$-0.2328.13%
05/06/2014---$-0.2720.59%
02/06/2014---$0.21362.50%
10/30/2013---$-0.43-330.00%
07/31/2013---$-0.58-7.41%
04/30/2013---$-0.541.82%
02/05/2013---$-0.4231.15%
10/30/2012---$-0.4233.33%
07/31/2012---$-0.78-2.63%
04/26/2012---$-0.789.30%
02/02/2012---$-0.969.43%
10/27/2011---$-0.9023.08%
07/28/2011---$-1.38-115.63%
04/27/2011---$-1.085.26%
02/14/2011---$-1.0223.31%
10/28/2010---$-1.148.80%
07/28/2010---$-1.26-4.13%
04/29/2010---$-1.20-0.84%
02/03/2010---$-1.264.55%
10/28/2009---$-0.8434.88%
07/29/2009---$5.9496.69%
04/30/2009---$-1.26-0.80%
02/10/2009---$-1.3243.10%
10/30/2008---$-1.9810.00%
07/31/2008---$-1.866.53%
04/29/2008---$-1.6811.58%
01/31/2008---$-1.6233.33%
10/31/2007---$-1.4438.72%
07/31/2007---$-1.6225.35%
04/26/2007---$-1.5037.76%
01/31/2007---$-2.4629.51%
10/26/2006---$-2.4618.27%
07/27/2006---$-2.2223.18%
04/27/2006---$-2.1625.77%
01/31/2006---$-2.2819.43%
10/26/2005---$-2.1013.93%
07/27/2005---$-2.2218.98%
04/27/2005---$-2.2217.16%
02/03/2005---$-2.52-6.78%
10/21/2004---$-2.1625.00%
07/28/2004---$-2.78---
06/16/2004---$-1.33---

More About Cytokinetics Inc

Website
https://www.cytokinetics.com
Country
USA
Full Time Employees
498

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. It also develops CK- 089, a fast skeletal muscle troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase II clinical trial; and aficamten, a novel, oral, small molecule cardiac myosin inhibitor which is in Phase III clinical trial discovered for the treatment of hypertrophic cardiomyopathy. It has a strategic alliance with Ji Xing Pharmaceuticals Limited; and a collaboration and license agreement for the development and commercialization of aficamten in Japan for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

“Cytokinetics Inc Earnings” Can Refer to the Cytokinetics Inc Earnings Date

Some people say “Cytokinetics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Cytokinetics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Cytokinetics Inc Stock on the Earnings Date

If you own Cytokinetics Inc stock (CYTK) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Cytokinetics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Cytokinetics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Cytokinetics Inc Earnings

You can contact us any time if you would like to ask questions about Cytokinetics Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.